characteristics.text: SAMN47290182
characteristics.characteristic: External Id
characteristics.text: Experimental Immunology, Helmholtz-Centre for Infection Research
characteristics.characteristic: INSDC center name
characteristics.text: 2025-12-04T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-12-04T10:01:07.692Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS24303647
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS24303647
characteristics.characteristic: SRA accession
characteristics.text: CD8+ effector T cells
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: CD3+CD8+CD45RA−/+CCR7−
characteristics.characteristic: marker
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: peripheral blood
characteristics.characteristic: source_name
characteristics.text: peripheral blood
characteristics.characteristic: tissue
characteristics.text: CD8+ effector T cells, ZEB2 knockout, experiment 1, donor 120
characteristics.characteristic: title
characteristics.text: Electroporation of CRISPR/Cas9 ribonucleoprotein complex (containing ZEB2 specific Alt-R® CRISPR Cas9 cRNAs (IDT), 2 days stimulation with plate-bound anti-CD3 and anti-CD28 antibodies (both 0.5µg/ml).
characteristics.characteristic: treatment